The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tracking plasticity along with proliferation and immune evasion using FOXC1, MKI67 and PDL1 for prediction of therapeutic response and risk for hyperprogressive disease with PD1/PDL1 inhibitors in advanced/metastatic cancers: Pan-tumor validation in clinical trial and real-world cohorts.
 
Partha S Ray
Stock and Other Ownership Interests - 3N Diagnostics; Onconostic Technologies
Patents, Royalties, Other Intellectual Property - Patents related to FOXC1
(OPTIONAL) Uncompensated Relationships - Onconostic Technologies
 
Tania Ray
Stock and Other Ownership Interests - 3N Diagnostics; Onconostic Technologies
(OPTIONAL) Uncompensated Relationships - Onconostic Technologies
 
Clive R Taylor
Stock and Other Ownership Interests - 3N Diagnostics; Onconostic Technologies
(OPTIONAL) Uncompensated Relationships - Onconostic Technologies
 
Robert Hussa
Stock and Other Ownership Interests - Stock
(OPTIONAL) Uncompensated Relationships - Research/Development